7.53
+0.255(+3.51%)
Currency In USD
| Previous Close | 7.27 |
| Open | 7.36 |
| Day High | 8.19 |
| Day Low | 7.2 |
| 52-Week High | 3,500.42 |
| 52-Week Low | 6.2 |
| Volume | 57,092 |
| Average Volume | 34,050 |
| Market Cap | 4.38M |
| PE | -0.65 |
| EPS | -11.5 |
| Moving Average 50 Days | 7.13 |
| Moving Average 200 Days | 697.83 |
| Change | 0.26 |
If you invested $1000 in Aclarion, Inc. (ACON) since IPO date, it would be worth $0.02 as of July 01, 2025 at a share price of $7.525. Whereas If you bought $1000 worth of Aclarion, Inc. (ACON) shares 2 years ago, it would be worth $0.07 as of July 01, 2025 at a share price of $7.525.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
First Patient Enrolled in Aclarion’s Groundbreaking CLARITY Trial
GlobeNewswire Inc.
Jun 25, 2025 10:00 AM GMT
The first CLARITY patient was enrolled at the Texas Back Institute, a world leader in advancing spine technology, science, and education, as well as patient careCLARITY is a randomized clinical trial designed to demonstrate Nociscan’s ability to impr
Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum
GlobeNewswire Inc.
Jun 24, 2025 11:00 AM GMT
Dr. Kris Radcliff to Highlight MR Spectroscopy and Augmented Intelligence (AI)-Based Platform at State of Spine Surgery Think TankBROOMFIELD, Colo., June 24, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACON
Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site
GlobeNewswire Inc.
Jun 10, 2025 10:00 AM GMT
UHealth — University of Miami Health System and the University of Miami Miller School of Medicine provide world-class research and renowned clinical expertise in spine surgeryCLARITY is a prospective, randomized clinical trial designed to demonstrate